Top Markets
Coin of the day
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock

Hemab Therapeutics Holdings, Inc. Common Stock

COAG
Hisse Senetlerindeki Sıralama #21709
Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm... Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody. This asset is currently undergoing Phase 1/2 clinical trials for the preventive management of Glanzmann thrombasthenia and has progressed to Phase 2 for the prophylactic treatment of Factor VII deficiency. Additionally, Hemab is advancing HMB-002, a monovalent antibody, through Phase 1/2 clinical development. This drug is designed for the subcutaneous prophylactic treatment of Von Willebrand disease. Beyond these clinical assets, the company actively pursues numerous preclinical and discovery-stage programs. Established in 2020, Hemab Therapeutics Holdings, Inc. maintains its headquarters in Cambridge, Massachusetts.
Hisse Fiyatı
$50.82
Son senkronizasyon: 2026-08-11
Piyasa Değeri
$102.09M
Değişim (1 gün)
1.90%
Değişim (1 yıl)
-
Ülke
US
Ticaret Hemab Therapeutics Holdings, Inc. Common Stock (COAG)

Kategori

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) için hisse bölünme geçmişi
Hemab Therapeutics Holdings, Inc. Common Stock hissesi (sembol: COAG) toplamda 0 hisse bölünmesi yaşamıştır.
En son hisse bölünmesi Aug 23, 2026 tarihinde gerçekleşmiştir.
Aug 23, 2026 tarihinden önce alınan bir COAG hissesi bugün 0 COAG hissesine eşdeğerdir.
Hisse bölünme listesi
Yıl Bölünme Çarpan Kümülatif Çarpan
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için hisse bölünmeleri
Şirket Hisse bölünme sayısı Kümülatif Çarpan Ülke
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH